During the past decade, SCM Dr. Rosu conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "SCM Dr. Rosu" #1 collaborator was "Opera CRO, a TIGERMED Group Company" with 9 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "SCM Dr. Rosu" are "Cicatrix" (4 trials), "Lipodystrophy" (4 trials), "Plaque" (4 trials), "Wrinkle" (3 trials) and "Metabolic Syndrome" (1 trials). Many other conditions were trialed in "SCM Dr. Rosu" in a lesser frequency.

Most popular intervention types in "SCM Dr. Rosu" are "Device" (8 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Auralya" (2 trials), "Jalucomplex" (2 trials), "Daily administration: 2 tablets FaseMETS a day" (1 trials), "Janesse" (1 trials) and "Janesse® is a sterile, injectable, non-pyrogenic, re-absorbable medical product made of reticulated hyaluronic acid of non-animal origin, produced via bacterial fermentation." (1 trials). Other intervention names were less common.

The vast majority of trials in "SCM Dr. Rosu" are 9 trials for "All" genders.

Currently, there are NaN active trials in "SCM Dr. Rosu". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in SCM Dr. Rosu, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SCM Dr. Rosu, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".